It is a anatomical malformation of the heart or great vessels which occur during intrauterine development, irrespective of the age at presentation. The most common type of pediatric heart disease is congenital, meaning that children are born with it. The effect of this condition causes heart palpitation, shortness of breath, chest pain etc.
Congenital Cardiovascular disease is the most common heart disease It can be detected before birth, soon after birth or anytime throughout life. There are many different types of congenital heart defects. and can be broken down into common categories, such as: cyanotic congenital heart disease, ductal dependent congenital heart disease, critical congenital heart disease, and other acyanotic or less acute congenital heart defects. Symptoms and treatment depend on the type of defect and its severity. Minor defects may not require treatment. Others may require blood pressure lowering medications, heart devices, catheter procedures and surgery. Serious cases may require heart transplant. The problem can affect the heart walls, heart valves and the blood vessels.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India